CDI Announces an iCell® Workshop in London, UK: Advances in Human iPSC-derived Cell Models for Phenotypic Screening & Toxicity Studies. Register today...
Join CDI at the 2013 User Group Meeting,
Aug 26 - 28. Learn more...
CDI’s iCell Cardiomyocytes were discussed during a recent American Journal of Physiology podcast. Authors describe published research detailing the electrophysiological characterization of iCell Cardiomyocytes.
The Power of iPS Cell Technology: Any cell type. Any genetic background. Any quantity. These cells deliver. Read more...
With 100+ employees and >700 patents, CDI manufactures human iPS cell-derived cell types with the quality, quantity, and purity required for basic life science and drug discovery research. Read more...
May 1, 2013
GEN
Human iPSC-Derived Hepatocytes: Functional Model Tissue for In Vitro Predictive Metabolism, Toxicity, and Disease Modeling
Apr 5, 2013
Foundation Fighting Blindness
Stem Cell Pioneers Creating Retinal Patch to Restore Vision
Apr 1, 2013
CDI Press Release
Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
Mar 21, 2013
CDI Press Release
Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
May 20, 2013
Cellular Dynamics iCell Workshop
London, UK
Aug 26 - 28, 2013
CDI User Group Meeting
Madison, WI
|
iCell Cardiomyocytes |
|
iCell Endothelial Cells |
|
iCell Neurons |
|
iCell Hepatocytes |
Have a unique genotype? MyCell Products provide a complete suite of iPS cell reprogramming, genetic engineering, and cell differentiation services to meet your research needs.
